RecruitingNCT07220460
This study is looking at assess how safe and effective ABBV-932 is in treating participants with depressive episodes associated with bipolar I or II disorder. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Bipolarity
RecruitingNCT05303064
This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to OLZ/SAM, but direct benefit is not guaranteed.
BipolarityDrugFrom 10 Years to 17 Years
- Countries
- United States, Argentina, Brazil, Colombia, Mexico
- Sponsor
- Alkermes, Inc.
- Condition
- Bipolarity
RecruitingNCT02604277
This study is looking at learn the environmental and psychological factors that impact suicidality in patients diagnosed with bipolarity for people with Depression, Alcoholism, or Drug Abuse. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityBehavioralFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Emory University
- Condition
- Bipolarity
RecruitingNCT06700902
This study is looking at whether questionnaires and follow-up can help people with depression, bipolarity, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.
DepressionBehavioralOver 18 Years
- Countries
- United States
- Sponsor
- Temple University
- Condition
- Depression
RecruitingNCT05786066
This study is comparing Perampanel 6 MG with placebo for people with depression, bipolarity, Post Traumatic Stress Disorder, or Suicidal Ideation. Participants receive Perampanel 6 MG or placebo and complete study visits and assessments.
DepressionDrugFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Depression
RecruitingNCT04296604
This observational study is following people with depression, psychosis, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionDeviceFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
Active Not RecruitingNCT05172271
This study is comparing MagPro TMS Stimulator and coil with Sham TEST for people with depression, bipolarity, or Unipolar Major Depression. Participants receive MagPro TMS Stimulator and coil or Sham TEST and complete study visits and assessments.
DepressionDeviceFrom 25 Years to 64 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Depression
Active Not RecruitingNCT04358900
This observational study is following people with depression or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 25 Years to 50 Years
- Countries
- United States
- Sponsor
- University of Illinois at Chicago
- Condition
- Depression
RecruitingNCT06373016
This study is looking at care and outcomes for people with bipolarity or bipolarity Type 1. Taking part may give some people access to Glucose, but direct benefit is not guaranteed.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Stony Brook University
- Condition
- Bipolarity
Active Not RecruitingNCT04675593
This study is looking at whether iTAB-CV can help people with bipolarity, Non-Adherence, Medication, Hypertension, or depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionBehavioralFrom 21 Years to 80 Years
- Countries
- United States
- Sponsor
- Case Western Reserve University
- Condition
- Depression
RecruitingNCT06204705
This observational study is looking at how a digital support tool works for people with bipolarity in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Bipolarity
RecruitingNCT06897670
This observational study is following people with depression, bipolarity, or Mild Cognitive Impairment to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT06462196
This study is looking at be conducted at the NIH Clinical Center in Bethesda, MD for people with depression or bipolarity. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionOtherFrom 18 Years to 120 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Depression
Active Not RecruitingNCT06002204
This observational study is following people with Depression, Treatment Resistant Depression, bipolarity, or Mental Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionOtherOver 10 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Depression
RecruitingNCT04480918
This study is looking at examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD) for people with depression or bipolarity. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionDeviceFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mark Niciu
- Condition
- Depression
RecruitingNCT03748446
This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
RecruitingNCT05025605
This study is comparing BXCL501 80 Micrograms with placebo for people with psychosis or bipolarity. Participants receive BXCL501 80 Micrograms or placebo and complete study visits and assessments.
BipolarityDrugFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Bipolarity
Active Not RecruitingNCT03788811
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityDeviceFrom 18 Years to 50 Years
- Countries
- United States, Australia, Canada
- Sponsor
- diaMentis Inc.
- Condition
- Bipolarity
RecruitingNCT06229210
This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityDrugFrom 5 Years to 17 Years
- Countries
- United States, Serbia
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity
RecruitingNCT06911931
This study is looking at identify novel markers of psychosis using electroencephalography (EEG) for people with Schizophrenia Disorders, bipolarity, or Schizo Affective Disorder. Taking part may give some people access to EEG measure of visual processing, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Rochester
- Condition
- Schizophrenia
RecruitingNCT07494305
This study is comparing LB-102 with placebo for people with Bipolarity I. Participants receive LB-102 or placebo and complete study visits and assessments.
BipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
- Condition
- Bipolarity
RecruitingISRCTN44497123
This study is looking at whether A randomized controlled trial with three groups was created can help people with Multimorbidity or Other. Participants take part in A randomized controlled trial with three groups was created and complete follow-up assessments.
SchizophreniaOther
- Countries
- Algeria, United States, Andorra, Angola, United Kingdom, Antarctica, Antigua and Barbuda, Argentina, Armenia, Netherlands, Taiwan
- Sponsor
- National Defense Medical Center
- Condition
- Schizophrenia
RecruitingISRCTN11314056
This study is looking at care and outcomes for people with bipolarity or Mental and Behavioural Disorders. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- Bipolarity
RecruitingISRCTN21059161
This study is looking at whether Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 can help people with Serious mental illnesses including schizophrenia, bipolarity, and schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, Bipolarity. Participants take part in Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 and complete follow-up assessments.
SchizophreniaOther
- Countries
- United States
- Sponsor
- VA Health Services Research & Development (USA)
- Condition
- Schizophrenia
RecruitingISRCTN97160532
This study is looking at whether a digital support tool can help people with bipolarity-I, most recent episode manic or mixed, with or without psychotic features, Mental and Behavioural Disorders, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityOtherOver 18 Years
- Countries
- Turkey, United States
- Sponsor
- The Stanley Medical Research Institute (SMRI) (USA)
- Condition
- Bipolarity